Table 4. LncRNAs potentially serve as therapeutic targets for RCC.
LncRNAs | Location | Properties/Mechanisms | References |
---|---|---|---|
HOTAIR | chromosome 12 | recruit and bind on the locus of EZH2 and H3K27me3 | 80 |
inhibit cycle-related genes p53, p21 and p16 | 80 | ||
modulate covalent histones | 80 | ||
interact with methyltransferase PRC2, histone demethylase LSD1 | 80 | ||
regulates gene silencing | 80 | ||
required for H3K27 trimethylation | 81 | ||
transcriptional silencing across the HOXD locus | 81 | ||
RCCRT1 | chr5:137801181-137805004 | upregulated in RCC | 49 |
upregulated predicts poor survival of RCC | 49 | ||
MALAT1 | chromosome 11q13 | independent predictor of OS in ccRCC | 50, 51 |
sequester serine/arginine splicing factors in nuclear speckle domains | 83, 84 | ||
regulate alternative splicing | 84 | ||
transcriptional activation of MALAT1 by c-Fos contribute to oncogenesis | 51 | ||
interact with Ezh2 | 51 | ||
reciprocally repressed with miR205 | 51 | ||
regulate EMT via E-cadherin and β-catenin | 51 | ||
promote ZEB2 expression by sponging miR-200s | 85 | ||
H19 | 11p15.5 | exon 1 of H19 harbors a miRNA-containing hairpin | 86 |
serve as the template of two miR6755p and miR6753p | 86 | ||
LncRNA-SRLR | 3q24 | upregulated in intrinsically sorafenib resistant RCC | 87 |
LncARSR | 9q82.120.717-82.185.824 | promote sunitinib resistance of RCC | 88 |
competitively bind to miR-34/miR-449 | 88 | ||
facilitate AXL and c-MET expression | 88 | ||
exosome-transferred lncARSR confer sunitinib resistance | 88 | ||
targeting lncARSR restores sunitinib response in RCC | 88 | ||
CADM1-AS1 | antisense direction of a coding exon ofthe cell adhesion molecule 1 (CADM1) | involved in renal carcinogenesisindependent prognostic factor for ccRCC |
60 60 |